Imperial Brands has delivered a half-year update that looks better underneath the bonnet than the headline profit drop suggests. The market was always likely to focus on the ugly reported numbers first, but the more important takeaway is that pricing remains strong, cash generation is still excellent, and shareholder returns are moving higher.
My read is that this is a steady rather than spectacular set of H1 2026 results. The core tobacco business is still doing the heavy lifting, next generation products are growing, and management says full-year guidance is unchanged. That matters because this is a business investors usually buy for resilient cash flow, dividends, and buybacks – and all three are still firmly in the picture.
Imperial Brands H1 2026 key numbers: revenue, profit, dividend and debt
| Metric | H1 2026 | H1 2025 | Change |
|---|---|---|---|
| Reported revenue | £14,719 million | £14,604 million | +0.8% |
| Tobacco & NGP net revenue | £3,729 million | £3,664 million | +1.8% |
| Reported operating profit | £925 million | £1,456 million | -36.5% |
| Adjusted operating profit | £1,644 million | £1,652 million | +0.6% at constant currency |
| Reported EPS | 59.9p | 96.7p | -38.1% |
| Adjusted EPS | 127.7p | 123.9p | +5.3% at constant currency |
| Interim dividend per share | 83.36p | 80.16p | +4.0% |
| 12-month free cash flow | £2.6 billion | Not disclosed | Not disclosed |
Imperial Brands tobacco pricing offsets volume decline in H1 2026
The central investment case is still intact: cigarette volumes are falling, but pricing is more than making up for it. Tobacco volumes dropped by 1.5% to 85.7 billion stick equivalents, while tobacco net revenue still rose by 1.5% thanks to pricing of 3.0%.
That is exactly what investors want to see from a tobacco major. Volume pressure is normal in this sector, so the test is whether management can keep pushing price without breaking demand too hard. For now, Imperial is passing that test.
There was a small wobble on market share, with aggregate market share across priority markets down 16 basis points. Management says this reflects being more selective and focusing on more profitable segments. That can be sensible, but it is still worth watching because repeated share losses can eventually make pricing power harder to sustain.
Imperial Brands adjusted profit versus reported profit: why the gap is so big
This is the part retail investors need to understand clearly. Imperial reports two sets of numbers: reported and adjusted. Reported numbers include all costs. Adjusted numbers strip out items management sees as one-offs or non-underlying, to show the trading picture more cleanly.
On a reported basis, operating profit fell 36.5% to £925 million and earnings per share dropped 38.1% to 59.9p. That is a big decline, and it is not something to brush aside completely.
But the main reason is not a collapse in day-to-day trading. The release points to higher costs from the Delaware settlement and spending on the 2030 Strategy. On an adjusted basis, operating profit actually grew 0.6% at constant currency, and adjusted earnings per share rose 5.3%.
That tells me the underlying business is still stable, even if statutory profitability took a hit. The negative is obvious – cash is still cash, and exceptional charges still matter. The positive is that this does not look like a core trading problem.
Next generation products growth is encouraging, but Imperial Brands is not there yet
Imperial’s next generation products, or NGP, had a decent half. NGP net revenue rose 7.5%, with particularly strong growth in AAACE at 60.0% and Europe at 15.3%. The company also said it gained market share in all three NGP categories.
That is encouraging because Imperial needs these products to become a bigger part of the story over time. Heated tobacco was highlighted as especially strong, helped by the Pulze 3.0 rollout. Modern oral also did well in Europe, while the US Zone brand gained volume share.
Still, there is a catch. NGP made an adjusted loss of £40 million, which was £3 million worse than the prior year. So yes, growth is there, but this is not yet a profit engine on the numbers provided.
The company expects a stronger second half for NGP, helped by new Zone flavour launches and targeted execution. That sounds reasonable, but investors will want to see growth convert into better profitability, not just higher sales.
Imperial Brands cash flow, dividend and buyback remain the biggest positives
This is where the update gets genuinely attractive for income-focused shareholders. Imperial generated 12-month free cash flow of £2.6 billion and reported adjusted operating cash conversion of around 98% on a 12-month basis. That is strong and shows the business is still converting profits into hard cash.
The interim dividend has been lifted by 4.0% to 83.36p per share. On top of that, Imperial completed £809 million of share buybacks in the period and said a £1.45 billion buyback is underway this year.
That combination matters. A rising dividend and a large buyback both support total shareholder returns, and the falling share count also helped adjusted earnings per share growth in the half.
There is, however, a debt angle to keep in mind. Reported net debt increased to £10,943 million from £10,471 million, while adjusted net debt was £10,518 million versus £9,956 million. The leverage ratio stayed flat at 2.4x on an adjusted net debt to EBITDA basis, and management expects that to move to around 2.0x by year end, which would be more comfortable.
Imperial Brands 2030 Strategy and Delaware settlement: what investors should make of them
The Delaware settlement is a real drag on reported numbers and cash. Imperial paid £150 million to R J Reynolds in the period, with another £162 million due in instalments over the next three years. That is manageable, but it is still money leaving the business that could otherwise have gone elsewhere.
On transformation, the message is that management is investing now to build a leaner, more data-led business later. It says it is on track to deliver £320 million of annual cost savings by 2030. The Capgemini partnership and the transfer of 386 roles were highlighted as part of that plan.
In principle, that is positive. The risk is execution. Big transformation programmes often sound good in slides before the savings fully turn up in the numbers. For now, I would treat this as promising but not proven.
Imperial Brands outlook for FY26: guidance held, but risks have not disappeared
Management left full-year guidance unchanged, which is reassuring. Imperial still expects low-single-digit tobacco net revenue growth, double-digit NGP net revenue growth, and group adjusted operating profit growth of 3% to 5% at constant currency.
It also expects at least £2.2 billion of free cash flow in FY26 and at least high single-digit adjusted earnings per share growth for the full year. That is a solid outlook and suggests confidence in a stronger second half.
The main risk flagged in the release is the conflict in the Middle East, which could hurt input costs, consumer demand, and duty free if it drags on. Management says there has been no material impact so far. Foreign exchange is also expected to be a modest headwind of 0% to 1.0%.
What Imperial Brands H1 2026 results mean for retail investors
This was a good enough half-year update, not a knockout one. The underlying business is holding up, pricing is doing its job, cash flow is strong, and the dividend and buyback remain attractive. Those are the pillars most Imperial shareholders care about.
The negatives are also real. Reported profit was hit hard, debt is higher than last year, NGP is still lossmaking, and market share slipped in priority markets. None of that breaks the story today, but it does stop this being an easy, carefree set of results.
My verdict: cautiously positive. If you own Imperial Brands for dependable cash returns and steady execution, this update largely supports that case. If you were hoping for a clean breakout in growth or a dramatic improvement in reduced-risk products profitability, you did not get that yet.
